CRBP

CORBUS PHARMACEUTICALS HLDGS

CRBP·21833P301·US·Common Stock·Healthcare - Biotechnology-13D/G

CRBP (CORBUS PHARMACEUTICALS HLDGS) is held by 58 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($12.5M), Aberdeen Group plc ($12.4M), VANGUARD CAPITAL MANAGEMENT LLC ($7.1M). Net institutional sentiment: Mixed.

58
Holders
(3 Elite)
$59.9M
Total Value
53% (62)
Consensus
33 buying - 29 selling
13F: Insider & Congress: Updated regularly
CRBP

Smart Money Verdict

View all
Loading verdict
Held by 58 funds
3 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistCitadel Securities LLCCitadel Securities LLC1.1%Aug 14, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.9%Jul 27, 2026
ActivistOAOctagon Capital Advisors LP0.0%May 14, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
1.3M(+390.0%)$12.5M0.0%-51.20%
45
Unchanged
1.3M$12.4M0.0%-45.03%
0
Increased
760,940(+3.7%)$7.1M0.0%-42.07%
28
Increased
423,374(+126.4%)$4M0.0%-71.32%
43
Decreased
293,203(-12.1%)$2.8M0.0%-50.66%
0
Increased
254,672(+269.8%)$2.4M0.0%-69.28%
42
Increased
190,214(+39.3%)$1.8M0.0%-43.49%
34
Decreased
151,640(-5.5%)$1.4M0.0%-70.31%
0
Increased
139,133(+90.1%)$1.3M0.0%-52.83%
40
Increased
124,906(+200.9%)$1.2M0.0%-62.00%
41
Increased
112,397(+16.8%)$1.1M0.0%-42.95%
29
Increased
111,302(+356.8%)$1M0.0%-47.61%
28
Decreased
110,822(-68.1%)$1M0.0%-41.57%
0
Decreased
92,154(-87.3%)$864,4050.0%-40.32%
0
Decreased
79,331(-45.9%)$744,1250.0%-51.49%
0
Increased
78,120(+644.8%)$732,7660.0%-48.18%
40
Increased
67,654(+77.9%)$634,5950.0%-45.20%
37
Decreased
62,863(-32.5%)$589,6550.0%-74.04%
0
New
55,455$520,1680.0%-49.04%
33
New
55,224$504,7470.0%-49.04%
33

Showing 1-20 of 71

1 / 4
CRBPCRBPCORBUS PHARMACEUTICALS HLDGS

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used